Top Markets
#1 Siacoin Siacoin +14.92%
#2 B3 (Base) B3 (Base) +8.29%
#3 The Black Bull The Black Bull +4.42%
#4 MVL MVL +4.32%
#5 TROLL TROLL +4.30%
#6 BORA BORA +3.14%
#7 Power Ledger Power Ledger +2.58%
#8 Pieverse Pieverse +2.47%
#9 Vision Vision +2.10%
#10 WYDE: End Hunger WYDE: End Hunger +2.00%
Coin of the day
Siacoin Siacoin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Energenesis Biomedical CO.,LTD. Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD.

6657
Classifica tra le azioni #22642
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered... Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
Prezzo delle azioni
$0.97305026
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$85.54M
Variazione (1 giorno)
1.16%
Variazione (1 anno)
-50.40%
Paese
TW
Scambia Energenesis Biomedical CO.,LTD. (6657)

Categoria

Healthcare
EPS per Energenesis Biomedical CO.,LTD. (6657)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Energenesis Biomedical CO.,LTD., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Energenesis Biomedical CO.,LTD. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH